Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

Lung and Thoracic cancer

Association of Immune-Related Adverse Events and the Efficacy of Anti–PD-(L)1 Monotherapy in Non–Small Cell Lung Cancer: Adjusting for Immortal-Time Bias

Ying Yu, Ning Chen, Sizhe Yu, Wanji Shen, Wanchen Zhai, Hui Li, Yun Fan

Cancer Res Treat. 2024;56(3):751-764. Published online January 2, 2024 DOI: https://doi.org/10.4143/crt.2023.1118

Combination of the LARS1 Inhibitor, BC-LI-0186 with a MEK1/2 Inhibitor Enhances the Anti-Tumor Effect in Non–Small Cell Lung Cancer

Sang Hoon Lee, Eun Young Kim, Jung Min Han, Gyoonhee Han, Yoon Soo Chang

Cancer Res Treat. 2023;55(3):851-864. Published online March 20, 2023 DOI: https://doi.org/10.4143/crt.2022.1527

Web of Science 2 Crossref 2

Clinical Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer Patients with Liver Metastases: A Network Meta-Analysis of Nine Randomized Controlled Trials

Qing Yin, Longguo Dai, Ruizhu Sun, Ping Ke, Liya Liu, Bo Jiang

Cancer Res Treat. 2022;54(3):803-816. Published online October 25, 2021 DOI: https://doi.org/10.4143/crt.2021.764

Web of Science 6 Crossref 5

Predictive Value of Interstitial Lung Abnormalities for Postoperative Pulmonary Complications in Elderly Patients with Early-stage Lung Cancer

Won Gi Jeong, Yun-Hyeon Kim, Jong Eun Lee, In-Jae Oh, Sang Yun Song, Kum Ju Chae, Hye Mi Park

Cancer Res Treat. 2022;54(3):744-752. Published online September 28, 2021 DOI: https://doi.org/10.4143/crt.2021.772

Web of Science 8 Crossref 7

miR-4487 Enhances Gefitinib-Mediated Ubiquitination and Autophagic Degradation of EGFR in Non-Small Cell Lung Cancer Cells by Targeting USP37

Mi Seong Kim, So Hui Kim, Sei Hoon Yang, Min Seuk Kim

Cancer Res Treat. 2022;54(2):445-457. Published online August 3, 2021 DOI: https://doi.org/10.4143/crt.2021.622

Web of Science 5 Crossref 3

Comparison of the Predictive Power of a Combination versus Individual Biomarker Testing in Non–Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors

Hyojin Kim, Hyun Jung Kwon, Eun Sun Kim, Soohyeon Kwon, Kyoung Jin Suh, Se Hyun Kim, Yu Jung Kim, Jong Seok Lee, Jin-Haeng Chung

Cancer Res Treat. 2022;54(2):424-433. Published online July 7, 2021 DOI: https://doi.org/10.4143/crt.2021.583

Web of Science 11 Crossref 5

Challenges in the Use of Targeted Therapies in Non–Small Cell Lung Cancer

Joel Rivera-Concepcion, Dipesh Uprety, Alex A. Adjei

Cancer Res Treat. 2022;54(2):315-329. Published online February 18, 2022 DOI: https://doi.org/10.4143/crt.2022.078

Web of Science 24 Crossref 24

EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation

Sehhoon Park, Bo Mi Ku, Hyun Ae Jung, Jong-Mu Sun, Jin Seok Ahn, Se-Hoon Lee, Keunchil Park, Myung-Ju Ahn

Cancer Res Treat. 2020;52(4):1288-1290. Published online June 22, 2020 DOI: https://doi.org/10.4143/crt.2020.278

Web of Science 18 Crossref 8

Lung cancer

Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea

Sun Min Lim, Sang-We Kim, Byoung Chul Cho, Jin Hyung Kang, Myung-Ju Ahn, Dong-Wan Kim, Young-Chul Kim, Jin Soo Lee, Jong-Seok Lee, Sung Yong Lee, Keon Uk Park, Ho Jung An, Eun Kyung Cho, Tae Won Jang, Bong-Seog Kim, Joo-Hang Kim, Sung Sook Lee, Im-II Na, Seung Soo Yoo, Ki Hyeong Lee

Cancer Res Treat. 2020;52(4):1112-1119. Published online May 15, 2020 DOI: https://doi.org/10.4143/crt.2020.245

Web of Science 15 Crossref 9

Caspase Recruitment Domain Containing Protein 9 Suppresses Non-Small Cell Lung Cancer Proliferation and Invasion via Inhibiting MAPK/p38 Pathway

Linyue Pan, Yuting Tan, Bin Wang, Wenjia Qiu, Yulei Yin, Haiyan Ge, Huili Zhu

Cancer Res Treat. 2020;52(3):867-885. Published online March 11, 2020 DOI: https://doi.org/10.4143/crt.2019.606

Web of Science 8 Crossref 7

Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea

Kangkook Lee, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn

Cancer Res Treat. 2020;52(1):292-300. Published online July 26, 2019 DOI: https://doi.org/10.4143/crt.2019.186

Web of Science 18 Crossref 14

Dummy Run of Quality Assurance Program before Prospective Study of Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases from Non-small Cell Lung Cancer: Korean Radiation Oncology Group (KROG) 17-06 Study

Eunah Chung, Jae Myoung Noh, Kyu Chan Lee, Jin Hee Kim, Weon Kuu Chung, Yang-Gun Suh, Jung Ae Lee, Ki Ho Seol, Hong Gyun Wu, Yeon Sil Kim, O Kyu Noh, Jae Won Park, Dong Soo Lee, Jihae Lee, Young Suk Kim, Woo-Yoon Park, Min Kyu Kang, Sunmi Jo, Yong Chan Ahn

Cancer Res Treat. 2019;51(3):1001-1010. Published online October 15, 2018 DOI: https://doi.org/10.4143/crt.2018.415

Web of Science 4 Crossref 4

Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea

Seonggyu Byeon, Youjin Kim, Sung Won Lim, Jang Ho Cho, Sehoon Park, Jiyun Lee, Jong-Mu Sun, Yoon-La Choi, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn

Cancer Res Treat. 2019;51(2):623-631. Published online July 23, 2018 DOI: https://doi.org/10.4143/crt.2018.151

Web of Science 43 Crossref 36

EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy

Song Ee Park, Jae Myoung Noh, You Jin Kim, Han Sang Lee, Jang Ho Cho, Sung Won Lim, Yong Chan Ahn, Hongryull Pyo, Yoon-La Choi, Joungho Han, Jong-Mu Sun, Se Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn

Cancer Res Treat. 2019;51(2):493-501. Published online June 18, 2018 DOI: https://doi.org/10.4143/crt.2018.125

Web of Science 27 Crossref 28

Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer

Young Saing Kim, Eun Kyung Cho, Hyun Sun Woo, Junshik Hong, Hee Kyung Ahn, Inkeun Park, Sun Jin Sym, Sun Young Kyung, Shin Myung Kang, Jeong-Woong Park, Sung Hwan Jeong, Jinny Park, Jae Hoon Lee, Dong Bok Shin

Cancer Res Treat. 2016;48(1):80-87. Published online March 2, 2015 DOI: https://doi.org/10.4143/crt.2014.307

Web of Science 15 Crossref 8

Pemetrexed-Erlotinib, Pemetrexed Alone, or Erlotinib Alone as Second-Line Treatment for East Asian and Non-East Asian Never-Smokers with Locally Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer: Exploratory Subgroup Analysis of a Phase II Trial

Dae Ho Lee, Jung Shin Lee, Jie Wang, Te-Chun Hsia, Xin Wang, Jongseok Kim, Mauro Orlando

Cancer Res Treat. 2015;47(4):616-629. Published online November 24, 2014 DOI: https://doi.org/10.4143/crt.2014.051

Crossref 8

Clinical Responses and Prognostic Indicators of Concurrent Chemoradiation for Non-small Cell Lung Cancer

Dong-Soo Lee, Yeon-Sil Kim, Jin-Hyoung Kang, Sang-Nam Lee, Young-Kyoun Kim, Myung-Im Ahn, Dae-Hee Han, Ie-Ryung Yoo, Young-Pil Wang, Jae-Gil Park, Sei-Chul Yoon, Hong-Seok Jang, Byung-Oak Choi

Cancer Res Treat. 2011;43(1):32-41. Published online March 31, 2011 DOI: https://doi.org/10.4143/crt.2011.43.1.32

Crossref 5

Gemcitabine and Carboplatin Combination Chemotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer: A Feasibility Study

Young Jin Yuh, Hyo Rak Lee, Sung Rok Kim

Cancer Res Treat. 2008;40(3):116-120. Published online September 30, 2008 DOI: https://doi.org/10.4143/crt.2008.40.3.116

Crossref 8

The Efficacy and Safety of Padexol® (Paclitaxel) and Cisplatin for Treating Advanced Non-small Cell Lung Cancer

Hoon-Kyo Kim, Jun Suk Kim, Hun Mo Ryoo, Dong Gun Shin, Byoung Young Shim, Kyong Hwa Park, Sung Hwa Bae, Chi Hong Kim

Cancer Res Treat. 2006;38(2):66-71. Published online April 30, 2006 DOI: https://doi.org/10.4143/crt.2006.38.2.66

Crossref 2

Results of Curative Radiation Therapy with or without Chemotherapy for Stage III Unresectable Non-Small Cell Lung Cancer

Sung-Ja Ahn, Young-Chul Kim, Kyu-Sik Kim, Kyung-Ok Park, Woong-Ki Chung, Taek-Keun Nam, Byung-Sik Nah, Ju-Young Song, Mi-Sun Yoon

Cancer Res Treat. 2005;37(5):268-272. Published online October 31, 2005 DOI: https://doi.org/10.4143/crt.2005.37.5.268

Crossref 2

Usefulness of Additional Delayed Regional F-18 Fluorodeoxy-glucose Positron Emission Tomography in the Lymph Node Staging of Non-Small Cell Lung Cancer Patients

Young So, June-Key Chung, Jae Min Jeong, Dong Soo Lee, Myung Chul Lee

Cancer Res Treat. 2005;37(2):114-121. Published online April 30, 2005 DOI: https://doi.org/10.4143/crt.2005.37.2.114

Crossref 5

A Phase II Trial of Docetaxel and Ifosfamide for Patients with Platinum-Resistant or Refractory Non-Small Cell Lung Cancer in a Salvage Setting

Gyeong-Won Lee, Jung-Hun Kang, Seok-Hyun Kim, Hea Yong Lee, Ho-Cheol Kim, Won-Sup Lee, Jong-Duk Lee, Young-Sil Hwang, Joung-Soon Jang, Jong-Seok Lee

Cancer Res Treat. 2004;36(5):287-292. Published online October 31, 2004 DOI: https://doi.org/10.4143/crt.2004.36.5.287

Crossref 1

Expression of c-kit and p53 in Non-small Cell Lung Cancers

Jinyoung Yoo, Chi Hong Kim, So Hyang Song, Byoung Yong Shim, Youn Ju Jeong, Meyung Im Ahn, Sung Whan Kim, Deog Gon Cho, Min Seop Jo, Kyu Do Cho, Hong Joo Cho, Hoon-Kyo Kim

Cancer Res Treat. 2004;36(3):167-172. Published online June 30, 2004 DOI: https://doi.org/10.4143/crt.2004.36.3.167

Crossref 5

The Effect of ZD 1839 (Iressa(R)) in the Treatment of Refractory Non Small Cell Lung Cancer

Yong Tai Kim, Chul Kim, Joo Hyuk Sohn, So Young Park, Soo Young Park, Nae Choon Yu, Young Sam Kim, Se Kyu Kim, Joon Chang, Kil Dong Kim, Kyung Young Chung, Joo Hang Kim

Cancer Res Treat. 2003;35(6):502-506. Published online December 31, 2003 DOI: https://doi.org/10.4143/crt.2003.35.6.502

Crossref 2

The Relation between Histopathologic Findings on Surgical Specimen and Outcomes in Patients with N2 Positive Stage IIIA Non-Small Cell Lung Cancer Receiving Preoperative Concurrent Radiochemotherapy and Surgery

Bo Kyong Kim, Kyoung Ju Kim, Yong Chan Ahn, Do Hoon Lim, Won Park, Joungho Han, Keunchil Park, Kwan Min Kim, Jhingook Kim, Young Mog Shim

Cancer Res Treat. 2003;35(6):497-501. Published online December 31, 2003 DOI: https://doi.org/10.4143/crt.2003.35.6.497

Relationship between PTEN and Vascular Endothelial Growth Factor Expression in Non-Small Cell Lung Cancer

Mee Sook Roh, Jae Ik Lee, Doo Kyung Yang, Soo Keol Lee, Hyuk Chan Kwon, Mi Kyoung Park, Ki Baek Hwang, Jin A Jung

Cancer Res Treat. 2003;35(5):445-450. Published online October 31, 2003 DOI: https://doi.org/10.4143/crt.2003.35.5.445

Crossref 3

Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer

L Chinsoo Cho, J Michael Dimaio, Randall Hughes, Phuc Nguyen, Paula Anderson, Hak Choy

Cancer Res Treat. 2003;35(5):373-382. Published online October 31, 2003 DOI: https://doi.org/10.4143/crt.2003.35.5.373

Effect of Combination Chemotherapy with Docetaxel Plus Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer

Hee Jung Kang, Min Kyoung Kim, Young Gil Kim, Jae Lyun Lee, Kyung Hee Lee, Myung Soo Hyun, Sung Hwa Bae, Hun Mo Ryoo

Cancer Res Treat. 2003;35(4):299-303. Published online August 31, 2003 DOI: https://doi.org/10.4143/crt.2003.35.4.299

Phase II Study of Gemcitabine and Vinorelbine as Second-Line Chemotherapy in Non-Small Cell Lung Cancer

Yoon Jae Kim, Joo Hyuk Sohn, Chul Kim, Yong Tai Kim, Hai Jin Kim, Joong Bae Ahn, Se Kyu Kim, Joon Chang, Nae Choon Yoo, Joo Hang Kim, Jae Yong Cho

Cancer Res Treat. 2003;35(4):294-298. Published online August 31, 2003 DOI: https://doi.org/10.4143/crt.2003.35.4.294

FDG-PET in Mediastinal Nodal Staging of Non-small Cell Lung Cancer: Correlation of False Results with Histopathologic Finding

Hee Jong Baek, Jin Haeng Chung, Jong Ho Park, Jae Ill Zo, Gi Jeong Cheon, Chang Woon Choi, Sang Moo Lim, Soo Yong Choi, Jong Myeon Hong, Jang Soo Hong

Cancer Res Treat. 2003;35(3):232-238. Published online June 30, 2003 DOI: https://doi.org/10.4143/crt.2003.35.3.232

Crossref 2